Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.

TitlePersistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
Publication TypeJournal Article
Year of Publication2017
AuthorsMcHugh D, Caduff N, Barros MHenrique M, Rämer PC, Raykova A, Murer A, Landtwing V, Quast I, Styles CT, Spohn M, Fowotade A, Delecluse H-J, Papoudou-Bai A, Lee Y-M, Kim J-M, Middeldorp J, Schulz TF, Cesarman E, Zbinden A, Capaul R, White RE, Allday MJ, Niedobitek G, Blackbourn DJ, Grundhoff A, Münz C
JournalCell Host Microbe
Volume22
Issue1
Pagination61-73.e7
Date Published2017 Jul 12
ISSN1934-6069
KeywordsAnimals, B-Lymphocytes, Cell Line, Tumor, Coinfection, Cytokines, Disease Models, Animal, DNA, Viral, Epstein-Barr Virus Infections, Gene Expression Regulation, Viral, Genes, Viral, Herpesviridae Infections, Herpesvirus 4, Human, Herpesvirus 8, Human, High-Throughput Nucleotide Sequencing, Humans, Lymphoma, Primary Effusion, Mice, Neoplasms, Spleen, Survival Rate, Virus Replication
Abstract

The human tumor viruses Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) establish persistent infections in B cells. KSHV is linked to primary effusion lymphoma (PEL), and 90% of PELs also contain EBV. Studies on persistent KSHV infection in vivo and the role of EBV co-infection in PEL development have been hampered by the absence of small animal models. We developed mice reconstituted with human immune system components as a model for KSHV infection and find that EBV/KSHV dual infection enhanced KSHV persistence and tumorigenesis. Dual-infected cells displayed a plasma cell-like gene expression pattern similar to PELs. KSHV persisted in EBV-transformed B cells and was associated with lytic EBV gene expression, resulting in increased tumor formation. Evidence of elevated lytic EBV replication was also found in EBV/KSHV dually infected lymphoproliferative disorders in humans. Our data suggest that KSHV augments EBV-associated tumorigenesis via stimulation of lytic EBV replication.

DOI10.1016/j.chom.2017.06.009
Alternate JournalCell Host Microbe
PubMed ID28704654
Grant List14-1033 / AICR_ / Worldwide Cancer Research / United Kingdom
Related Faculty: 
Ethel Cesarman, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700